The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 53
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2020 AND VI 34 AND IP 1
Results: 7
1
2
Location, Location, Location: Approaches to Retroperitoneal Vascular Leiomyosarcoma.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 43
- By:
- Publication type:
- Article
3
Locally Advanced Rectal Cancer, What is the Standard of Care?
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 31
- By:
- Publication type:
- Article
4
Finding the Next Line of Treatment in Melanoma.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 22
- By:
- Publication type:
- Article
5
FDA Approves First Agent to Treat Locally Advanced, Metastatic Urothelial Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 19
- By:
- Publication type:
- Article
6
CAR T-Cell Therapy Shows Promise in Multiple Hematologic Malignancies.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 16
- By:
- Publication type:
- Article
7
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non--Small Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 1, p. 1
- By:
- Publication type:
- Article